PRICE T ROWE ASSOCIATES INC /MD/ - APPLIED GENETIC TECHNOL CORP ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of APPLIED GENETIC TECHNOL CORP
ValueSharesWeighting
Q3 2022$30,000
-85.1%
108,680
-58.5%
0.00%
Q2 2022$202,000
-27.9%
262,0550.0%0.00%
Q1 2022$280,000
-43.8%
262,0550.0%0.00%
Q4 2021$498,000
-39.2%
262,055
-3.7%
0.00%
Q3 2021$819,000
-23.0%
272,1550.0%0.00%
Q2 2021$1,064,000
-23.6%
272,155
-0.9%
0.00%
Q1 2021$1,392,000
+29.0%
274,601
+4.1%
0.00%
Q4 2020$1,079,000
-15.8%
263,7360.0%0.00%
Q3 2020$1,282,000
-12.3%
263,7360.0%0.00%
Q2 2020$1,461,000
+69.9%
263,736
+0.6%
0.00%
Q1 2020$860,000
-27.4%
262,0550.0%0.00%
Q4 2019$1,184,000
+8.6%
262,0550.0%0.00%
Q3 2019$1,090,000
+9.8%
262,0550.0%0.00%
Q2 2019$993,000
-23.3%
262,055
-15.2%
0.00%
Q1 2019$1,295,000
+59.9%
309,000
-5.1%
0.00%
Q4 2018$810,000
-65.9%
325,4440.0%0.00%
Q3 2018$2,376,000
+41.3%
325,444
-28.4%
0.00%
Q2 2018$1,681,000
+130.0%
454,429
+139.2%
0.00%
Q1 2018$731,000
+6.9%
189,9810.0%0.00%
Q4 2017$684,000
-8.8%
189,9810.0%0.00%
Q3 2017$750,000
-22.6%
189,9810.0%0.00%
Q2 2017$969,000
-26.1%
189,981
-0.0%
0.00%
Q1 2017$1,311,000
-26.2%
190,0160.0%0.00%
Q4 2016$1,777,000
-4.4%
190,0160.0%0.00%
Q3 2016$1,858,000
-30.8%
190,016
+0.0%
0.00%
-100.0%
Q2 2016$2,684,000
+1.1%
189,9810.0%0.00%0.0%
Q1 2016$2,656,000
-31.5%
189,9810.0%0.00%0.0%
Q4 2015$3,876,000
+55.3%
189,9810.0%0.00%0.0%
Q3 2015$2,496,000
-14.3%
189,9810.0%0.00%0.0%
Q2 2015$2,914,000
-30.0%
189,981
-8.8%
0.00%0.0%
Q1 2015$4,163,000
-45.6%
208,235
-42.8%
0.00%
-50.0%
Q4 2014$7,648,000363,8570.00%
Other shareholders
APPLIED GENETIC TECHNOL CORP shareholders Q4 2022
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,455,904$7,075,0002.04%
DAFNA Capital Management LLC 1,095,139$5,322,0001.73%
Portolan Capital Management 1,301,075$6,323,0000.72%
Sofinnova Investments, Inc. 825,071$4,010,0000.30%
Ikarian Capital, LLC 545,884$2,654,0000.19%
683 Capital Management, LLC 364,299$1,770,0000.13%
Gyon Technologies Capital Management, LP 18,653$91,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 336,900$1,637,0000.07%
HighVista Strategies LLC 15,200$74,0000.05%
PURA VIDA INVESTMENTS, LLC 176,411$857,0000.04%
View complete list of APPLIED GENETIC TECHNOL CORP shareholders